Inovio Pharmaceuticals INO
NASDAQ INO
$0.89 +0.06 (+6.68%)
As of: Oct 23, 2026 · 1:36 PM EDT

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2011 - 2026)

Updated

Inovio Pharmaceuticals (INO) posted Return on Assets [ROA] of -156.22% for Q2 2026, down 37.29 percentage points from -118.93% a year earlier and down 24.58 percentage points from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Inovio Pharmaceuticals' Return on Assets [ROA] came in at -90.03%, down 14.14 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -41.04 percentage points (FY2020 to FY2025).
  • In prior years, Inovio Pharmaceuticals' Return on Assets [ROA] was -75.88% in FY2024 (-23.86 pp), -52.02% in FY2023 (+14.25 pp), -66.27% in FY2022 (-7.63 pp) and -58.64% in FY2021 (-9.65 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q3 2011.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last ten quarters, with an average year-over-year change of -25.63 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2023, with a gain of 10.49 percentage points; the weakest was Q2 2022, with a drop of 55.18 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -131.63% (Q1 2026), -117.47% (Q4 2025) and -126.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn 8.08%
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn 4.65%
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn 2.45%
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn 10.60%
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 9.10%
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn -6.13%
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 2.14%
10 Inovio Pharmaceuticals 73.13 Mn -110.54 Mn - -156.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -156.22%
Mar 31, 2026 -131.63%
Dec 31, 2025 -117.47%
Sep 30, 2025 -126.27%
Jun 30, 2025 -118.93%
Mar 31, 2025 -101.65%
Dec 31, 2024 -97.89%
Sep 30, 2024 -94.08%
Jun 30, 2024 -92.04%
Mar 31, 2024 -83.07%
Dec 31, 2023 -74.23%
Sep 30, 2023 -77.24%
Jun 30, 2023 -67.42%
Mar 31, 2023 -78.49%
Dec 31, 2022 -74.99%
Sep 30, 2022 -77.55%
Jun 30, 2022 -77.91%
Mar 31, 2022 -69.29%
Dec 31, 2021 -58.87%
Sep 30, 2021 -39.21%
API Access

Inovio Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INO&period=max&api_key=YOUR_API_KEY